Blog

Welcome to The Happy Lungs Project Blog. Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.

We seek to support researchers and clinicians in their work toward a cure for Non-Small Cell Lung Cancer caused by the RET mutation. We also aim to provide community resources and events to support finding a cure for RET-Positive lung cancer. On this blog, you will find information about our research, RET clinical trials, lung cancer education, upcoming events and more. Also, check out our patient Stories of Hope.

We would like to also welcome our guest blogger, Anthony “Nino” Sireci, M.D., vice president, clinical biomarker and diagnostics development at Lilly. Read Nino’s News.

Filter

ret cancer research sharing expertise
How Will the RET Research Network Accelerate Research?

How Will the RET Research Network Accelerate Research?

Learn how the RET Research Network speeds up RET-positive cancer research by sharing expertise, cell…
November 12, 2026
RET NET logo
Introducing the RET Research Network: A New Way to Advance RET Cancer Research

Introducing the RET Research Network: A New Way to Advance RET Cancer Research

The RET Research Network is a collaborative research initiative that brings together leading cancer research…
November 8, 2026
HLP RET cancer research update 2026
2026 RET Research Update: What the Experts Shared

2026 RET Research Update: What the Experts Shared

The 2026 Annual RET Research Update Webinar brought together leading researchers, clinicians and industry experts…
November 8, 2026
IASLC RET-positive podcast with Dr Aldea
IASLC Podcast: RET-Positive Lung Cancer with Dr. Aldea

IASLC Podcast: RET-Positive Lung Cancer with Dr. Aldea

Dr. Aldea explains what people with RET-positive lung cancer should know about treatment, testing, and…
October 19, 2026
2026 ret lung cancer research webinar
2026 RET Webinar: Meet Our Speakers

2026 RET Webinar: Meet Our Speakers

The 2026 RET Research Update is just around the corner, and we are excited to…
September 30, 2026
LCGS vaccine info for EGFR lung cancer
New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

New Large Study Analyzed Inherited EGFR T790M Mutation and Lung Cancer Risk

Inherited genetic factors can contribute to EGFR lung cancer risk, but the role of rare…
September 29, 2026
cancer vaccine success BioNTech
BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

BioNTech BNT116 Cancer Vaccine Shows Promising Early Activity in Resectable NSCLC

A new Phase I study, 53% of patients with available tissue had a major pathological…
September 24, 2026
kelli beyer patel HLP executive director
Meet Our New Executive Director

Meet Our New Executive Director

I joined The Happy Lungs Project at an exciting moment in its evolution. We have…
September 21, 2026
WCLC 2026 ret lung cancer research
New RET Research Advances from IASLC WCLC 2026

New RET Research Advances from IASLC WCLC 2026

IASLC World Conference on Lung Cancer (WCLC) 2026 featured important new research advancing the understanding…
September 16, 2026
Dr Alexandre Drilon Ret positive lung cancer researcher
New Study: Insights into the Role of Chemotherapy and Immunotherapy in RET-Positive Lung Cancer

New Study: Insights into the Role of Chemotherapy and Immunotherapy in RET-Positive Lung Cancer

A new study led by Dr. Alexander Drilon, member of HLP’s Scientific Advisory Board, finds…
September 14, 2026
new clinical trial for NSCLC
New Clinical Trial Evaluating Ivonescimab in Advanced NSCLC

New Clinical Trial Evaluating Ivonescimab in Advanced NSCLC

A new clinical trial at Massachusetts General Hospital is testing whether a dual-action immunotherapy can…
September 10, 2026
moderna mrna vaccine for NSCLC
Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Moderna’s Personalized mRNA Cancer Vaccine Programs in NSCLC

Learn how mRNA cancer vaccines like Moderna's V940 and mRNA-4359 are being studied in NSCLC…
September 3, 2026
genomic testing for lung cancer
RET-Fusion Positive NSCLC: Why Genomic Testing Matters for Your Treatment

RET-Fusion Positive NSCLC: Why Genomic Testing Matters for Your Treatment

Advances in biomarker science are reshaping how patients are diagnosed with and manage early-stage lung…
August 18, 2026
ctDNA liquid biopsy testing
ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

ctDNA and Liquid Biopsy in RET-Positive Lung Cancer

A simple blood draw can now reveal what's happening inside a tumor — no surgery…
August 12, 2026
RET inhibitor and chemotherapy treatment for lung cancer
Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

Continuing a RET Inhibitor With Chemotherapy After Progression May Improve Outcomes For RET Lung Cancer Patients

RET Inhibitor with chemotherapy after progression may improve outcomes for RET lung cancer patients
July 10, 2026